BPTES
SIGMA/SML0601 - ≥95% (HPLC)
Synonym: Bis-
CAS Number: 314045-39-1
Empirical Formula (Hill Notation): C24H24N6O2S3
Molecular Weight: 524.68
MDL Number: MFCD01079848
Linear Formula: C24H24N6O2S3
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C24H24N6O2S3/c31-19(15 |
| InChI key | MDJIPXYRSZHCFS-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(CC1=CC=CC=C1)NC2=NN=C |
| solubility | DMSO: 10 mg/mL, clear |
| storage temp. | 2-8°C |
| Application: | Bis-2-(5-phenylacetamido- |
| Biochem/physiol Actions: | BPTES is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. Glutaminase converts glutamine to glutamate, which is an important excitatory neurotransmitter in brain and can be further oxidized to α-ketoglutarate to feed the tricarboxylic acid (TCA) cycle and to glutathione, which is important for controlling the level of reactive oxygen species (ROS), particularly important for cancer cell growth. BPTES was found to slow growth of glioma cells. BPTES is a noncompetitive inhibitor with a Ki of 3 μM. |
| Biochem/physiol Actions: | BPTES is a selective inhibitor of Glutaminase GLS1. |
| Biochem/physiol Actions: | Vaccinia virus (VACV) requires glutamine metabolism for its optimal replication. Inhibition of glutaminolysis by bis-2-(5-phenylacetamido- |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


